Physician profile
Seth A Moore
NPI 1255593513
$1,325.78
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $799 · 2020: $30.63 · 2021: $21.50 · 2022: $187 · 2023: $194 · 2024: $93.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $287.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $531.64 | 2019 | |
| Abbvie INC. | $214.95 | 2019-2024 | |
| Olympus America INC. | $148.54 | 2022 | |
| Janssen Biotech, INC. | $97.72 | 2019-2022 | |
| Medtronic Vascular, INC. | $86.99 | 2019 | |
| Boston Scientific Corporation | $77.22 | 2023 | Watchman Access System, Habib Endohpb |
| Takeda Pharmaceuticals U.S.A., INC. | $40.93 | 2019 | |
| Celgene Corporation | $28.55 | 2023 | Zeposia |
| Allergan, INC. | $24.35 | 2019 | |
| Medtronic, INC. | $21.50 | 2021 | |
| Fresenius Kabi USA, LLC | $18.38 | 2023 | Idacio |
| Nestle Healthcare Nutrition INC. | $16.21 | 2023 | |
| Merck Sharp & Dohme LLC | $14.75 | 2019 | |
| Micro-Tech Endoscopy USA, INC. | $4.05 | 2024 | Endorotor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.